IDEXX Laboratories Inc (IDXX)
418.56
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 11:27
IDEXX Laboratories Total Liabilities (Quarterly): 1.733B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.733B |
| June 30, 2024 | 1.835B |
| March 31, 2024 | 1.785B |
| December 31, 2023 | 1.775B |
| September 30, 2023 | 1.789B |
| June 30, 2023 | 1.777B |
| March 31, 2023 | 1.967B |
| December 31, 2022 | 2.138B |
| September 30, 2022 | 2.164B |
| June 30, 2022 | 2.150B |
| March 31, 2022 | 1.953B |
| December 31, 2021 | 1.747B |
| September 30, 2021 | 1.630B |
| June 30, 2021 | 1.664B |
| March 31, 2021 | 1.624B |
| December 31, 2020 | 1.662B |
| September 30, 2020 | 1.606B |
| June 30, 2020 | 1.687B |
| March 31, 2020 | 1.778B |
| December 31, 2019 | 1.655B |
| September 30, 2019 | 1.549B |
| June 30, 2019 | 1.553B |
| March 31, 2019 | 1.629B |
| December 31, 2018 | 1.547B |
| September 30, 2018 | 1.546B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.562B |
| March 31, 2018 | 1.518B |
| December 31, 2017 | 1.767B |
| September 30, 2017 | 1.718B |
| June 30, 2017 | 1.723B |
| March 31, 2017 | 1.646B |
| December 31, 2016 | 1.639B |
| September 30, 2016 | 1.445B |
| June 30, 2016 | 1.498B |
| March 31, 2016 | 1.552B |
| December 31, 2015 | 1.559B |
| September 30, 2015 | 1.516B |
| June 30, 2015 | 1.469B |
| March 31, 2015 | 1.397B |
| December 31, 2014 | 1.267B |
| September 30, 2014 | 1.061B |
| June 30, 2014 | 830.26M |
| March 31, 2014 | 750.07M |
| December 31, 2013 | 712.30M |
| September 30, 2013 | 660.34M |
| June 30, 2013 | 614.48M |
| March 31, 2013 | 501.34M |
| December 31, 2012 | 467.34M |
| September 30, 2012 | 475.82M |
| June 30, 2012 | 477.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.606B
Minimum
Sep 2020
2.164B
Maximum
Sep 2022
1.806B
Average
1.776B
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies Inc | 5.093B |
| Bio-Rad Laboratories Inc | 3.116B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| West Pharmaceutical Services Inc | 923.00M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.351B |
| Shareholders Equity (Quarterly) | 1.618B |
| Debt to Equity Ratio | 0.5401 |
| Current Ratio | 1.421 |
| Net Debt Paydown Yield | 0.08% |